VYNDAQEL

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 7383754cecc1de56
Drug Approval Canada Name: VYNDAQEL
Product Name: VYNDAQEL
Status: Marketed
Status Date: 2020-04-07
Original Market Date: 2020-04-07
Din: 02495732
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:04.92
Atc Original: N07XX08 TAFAMIDIS
Atc Name: n 07 xx 08
Aig Number: 0162031001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

TAFAMIDIS MEGLUMINE

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7383754cecc1de56

Type

Standard